Table 1.
General characteristics of included patients in the study
| Number (% of total) | Mean age (years) [SD] | Gender (% male) | Median ACEI treatment duration (days) | Mean ACEI treatment duration (days) [SD] | |
|---|---|---|---|---|---|
| 3 Months interval | |||||
| Continuation (N = 503) (44.5 %) | |||||
| End of study | 267 (23.5) | 62 [6.7] | 50.2 | 1219 | 1340 [1035] |
| Out of study | 135 (12) | 62.9 [6.2] | 49.6 | 1350 | 1451 [1046] |
| Death | 101 (9) | 68.8 [7.3] | 51.5 | 508 | 756 [706] |
| Stop | 308 (27) | 64.5 [7] | 40.6 | 207.5 | 477 [628] |
| Switch to other antihypertensive than ARB | 134 (12) | 63.9 [6.5] | 45.5 | 116.5 | 419 [656] |
| Switch to ARB | 187 (16.5) | 62.7 [5.9] | 34.2 | 115 | 296 [464] |
| Total | 1132 (100) | 63.7 [6.9] | 44.4 | 343 | 785 [909] |
| 6 Months interval | |||||
| Continuation (N = 585) (51.5 %) | |||||
| End of study | 299 (26.5) | 62 [6.8] | 50.5 | 1207 | 1347 [1049] |
| Out of study | 167 (14.5) | 62.9 [6.1] | 48.5 | 1410 | 1533 [1047] |
| Death | 119 (10.5) | 69 [7.2] | 51.3 | 564 | 736 [673] |
| Stop | 261 (23 %) | 64.3 [6.9] | 40.2 | 179 | 466 [643] |
| Switch to other antihypertensive than ARB | 106 (9.5) | 64 [6.3] | 40.6 | 102.5 | 343 [532] |
| Switch to ARB | 180 (16) | 62.8 [5.7] | 34.4 | 115 | 293 [473] |
| Total | 1132 (100) | 63.7 [6.9] | 44.4 | 397 | 845 [948] |
ARB Angiotensin receptor blocker, SD standard deviation